Showing 1,201 - 1,220 results of 8,693 for search '"organizations"', query time: 0.05s Refine Results
  1. 1201
  2. 1202
  3. 1203
  4. 1204
  5. 1205
  6. 1206
  7. 1207
  8. 1208

    VIRTUAL RESEARCH ENVIRONMENT by S. Ulanin

    Published 2017-02-01
    Subjects: “…infrastructure research organization…”
    Get full text
    Article
  9. 1209
  10. 1210

    Dynamic capabilities and network benefits by Helge Svare, Anne Haugen Gausdal

    Published 2017-01-01
    Subjects: “…Regional Innovation Network Organizations (RINOs)…”
    Get full text
    Article
  11. 1211
  12. 1212
  13. 1213
  14. 1214
  15. 1215
  16. 1216

    Treatment Efficiency by means of a Nonthermal Plasma Combined with Heterogeneous Catalysis of Odoriferous Volatile Organic Compounds Emissions from the Thermal Drying of Landfill Leachates by Daniel Almarcha, Manuel Almarcha, Elena Jimenez-Coloma, Laura Vidal, Montserrat Puigcercós, Iban Barrutiabengoa

    Published 2014-01-01
    “…Odor concentration by means of dynamic olfactometry, total organic carbon, mercaptans, NH3, and H2S were also determined in order to assess the performance of the system throughout several days. …”
    Get full text
    Article
  17. 1217

    Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial by Brian Hiestand, Phillip Levy, W Frank Peacock, Brigitte M Baumann, Richard M Nowak, Amy Hsu, Joseph Varon, Chad M Cannon, David M Cline, Pierre Borczuk, Abhinav Chandra, Deborah B Diercks, Preeti Jois, Brian Kaminski, Jon W Schrock

    Published 2013-03-01
    “…Objective To compare the efficacy of Food and Drug Administration recommended dosing of nicardipine versus labetalol for the management of hypertensive patients with signs and/or symptoms (S/S) suggestive of end-organ damage (EOD).Design Secondary analysis of the multicentre prospective, randomised CLUE trial.Setting 13 academic emergency departments in the USA.Participants Eligible patients had two systolic blood pressure (SBP) measures ≥180 mm Hg at least 10 min apart, no contraindications to nicardipine or labetalol and predefined S/S suggestive of EOD on arrival.Interventions Medications were administered by continuous infusion (nicardipine) or repeat intravenous bolus (labetalol) for a study period of 30 min or until a specified target SBP ±20 mm Hg was achieved.Primary outcome measure Percentage of participants achieving a predefined target SBP range (TR) defined as an SBP within ±20 mm Hg as established by the treating physician.Results Of the 141 eligible patients, 49.6% received nicardipine, 51.7% were women and 81.6% were black. …”
    Get full text
    Article
  18. 1218
  19. 1219
  20. 1220

    ABO-incompatible liver transplantation – exploring utilitarian solutions to restricted access and organ shortages: A single-centre experience from Johannesburg, South Africa by E U Wessels, J Loveland, H Maher, P Gaylard, B Bobat, A D Mahomed, D Parbhoo, M R Beretta, C Hajinicolaou, P Walabh, S Berkenfeld, D Demopoulos, S Rambarran, B Ströbele, F van der Schyff, J Fabian, L Brannigan

    Published 2024-04-01
    “…This study confirms ABOi-LT as a feasible option to increase the liver donor pool in this organ-depleted setting as recipient survival and complication rates were similar between ABO-compatibility groups. …”
    Get full text
    Article